Streptococcus pneumoniae promotes lung cancer development and progression

Summary: Streptococcus pneumoniae (SP) is associated with lung cancer, yet its role in the tumorigenesis remains uncertain. Herein we find that SP attaches to lung cancer cells via binding pneumococcal surface protein C (PspC) to platelet-activating factor receptor (PAFR). Interaction between PspC a...

Full description

Bibliographic Details
Main Authors: Ning Li, Huifen Zhou, Van K. Holden, Janaki Deepak, Pushpa Dhilipkannah, Nevins W. Todd, Sanford A. Stass, Feng Jiang
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004222021964
_version_ 1828012388610211840
author Ning Li
Huifen Zhou
Van K. Holden
Janaki Deepak
Pushpa Dhilipkannah
Nevins W. Todd
Sanford A. Stass
Feng Jiang
author_facet Ning Li
Huifen Zhou
Van K. Holden
Janaki Deepak
Pushpa Dhilipkannah
Nevins W. Todd
Sanford A. Stass
Feng Jiang
author_sort Ning Li
collection DOAJ
description Summary: Streptococcus pneumoniae (SP) is associated with lung cancer, yet its role in the tumorigenesis remains uncertain. Herein we find that SP attaches to lung cancer cells via binding pneumococcal surface protein C (PspC) to platelet-activating factor receptor (PAFR). Interaction between PspC and PAFR stimulates cell proliferation and activates PI3K/AKT and nuclear factor kB (NF-kB) signaling pathways, which trigger a pro-inflammatory response. Lung cancer cells infected with SP form larger tumors in BALB/C mice compared to untreated cells. Mice treated with tobacco carcinogen and SP develop more lung tumors and had shorter survival period than mice treated with the carcinogen alone. Mutating PspC or PAFR abolishes tumor-promoting effects of SP. Overabundance of SP is associated with the survival. SP may play a driving role in lung tumorigenesis by activating PI3K/AKT and NF-kB pathways via binding PspC to PAFR and provide a microbial target for diagnosis and treatment of the disease.
first_indexed 2024-04-10T09:32:05Z
format Article
id doaj.art-8789b7b4553c495d976511e70a6e4052
institution Directory Open Access Journal
issn 2589-0042
language English
last_indexed 2024-04-10T09:32:05Z
publishDate 2023-02-01
publisher Elsevier
record_format Article
series iScience
spelling doaj.art-8789b7b4553c495d976511e70a6e40522023-02-19T04:26:33ZengElsevieriScience2589-00422023-02-01262105923Streptococcus pneumoniae promotes lung cancer development and progressionNing Li0Huifen Zhou1Van K. Holden2Janaki Deepak3Pushpa Dhilipkannah4Nevins W. Todd5Sanford A. Stass6Feng Jiang7Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USADepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD, USADepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USADepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USADepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD, USADepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USADepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD, USADepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA; Corresponding authorSummary: Streptococcus pneumoniae (SP) is associated with lung cancer, yet its role in the tumorigenesis remains uncertain. Herein we find that SP attaches to lung cancer cells via binding pneumococcal surface protein C (PspC) to platelet-activating factor receptor (PAFR). Interaction between PspC and PAFR stimulates cell proliferation and activates PI3K/AKT and nuclear factor kB (NF-kB) signaling pathways, which trigger a pro-inflammatory response. Lung cancer cells infected with SP form larger tumors in BALB/C mice compared to untreated cells. Mice treated with tobacco carcinogen and SP develop more lung tumors and had shorter survival period than mice treated with the carcinogen alone. Mutating PspC or PAFR abolishes tumor-promoting effects of SP. Overabundance of SP is associated with the survival. SP may play a driving role in lung tumorigenesis by activating PI3K/AKT and NF-kB pathways via binding PspC to PAFR and provide a microbial target for diagnosis and treatment of the disease.http://www.sciencedirect.com/science/article/pii/S2589004222021964BacteriologyCell biologyCellCancer systems biology
spellingShingle Ning Li
Huifen Zhou
Van K. Holden
Janaki Deepak
Pushpa Dhilipkannah
Nevins W. Todd
Sanford A. Stass
Feng Jiang
Streptococcus pneumoniae promotes lung cancer development and progression
iScience
Bacteriology
Cell biology
Cell
Cancer systems biology
title Streptococcus pneumoniae promotes lung cancer development and progression
title_full Streptococcus pneumoniae promotes lung cancer development and progression
title_fullStr Streptococcus pneumoniae promotes lung cancer development and progression
title_full_unstemmed Streptococcus pneumoniae promotes lung cancer development and progression
title_short Streptococcus pneumoniae promotes lung cancer development and progression
title_sort streptococcus pneumoniae promotes lung cancer development and progression
topic Bacteriology
Cell biology
Cell
Cancer systems biology
url http://www.sciencedirect.com/science/article/pii/S2589004222021964
work_keys_str_mv AT ningli streptococcuspneumoniaepromoteslungcancerdevelopmentandprogression
AT huifenzhou streptococcuspneumoniaepromoteslungcancerdevelopmentandprogression
AT vankholden streptococcuspneumoniaepromoteslungcancerdevelopmentandprogression
AT janakideepak streptococcuspneumoniaepromoteslungcancerdevelopmentandprogression
AT pushpadhilipkannah streptococcuspneumoniaepromoteslungcancerdevelopmentandprogression
AT nevinswtodd streptococcuspneumoniaepromoteslungcancerdevelopmentandprogression
AT sanfordastass streptococcuspneumoniaepromoteslungcancerdevelopmentandprogression
AT fengjiang streptococcuspneumoniaepromoteslungcancerdevelopmentandprogression